News

Bipartisan legislation introduced in the US House of Representatives seeks to exempt Food and Drug Administration user fees from sequestration starting from fiscal 2014.

Growing demand on A&E departments will make them unsustainable if effective action is not taken quickly to relieve the pressures on them, MPs warn.

Eight out of 10 UK patients diagnosed with the most dangerous form of skin cancer – malignant melanoma – will now survive their disease, compared with five out of 10 in the early 70s. 

Biogen Idec is funding a three-year collaboration with the University of Edinburgh in Scotland to explore the cell processes behind multiple sclerosis and motor neurone disease.

rtance of clinical-trialonsors raising awareness and highlighting patient-recruitment opportunities online.

Ireland’s medicines shortages have worsened significantly in the last 12 months, and the government must intervene to ensure that patients get the drugs they need, pharmacists have warned.

Isis Pharmaceuticals is “very encouraged” by a second set of mid-stage data for its heart drug APOIIIRx, which shows that it can substantially slash levels of dangerous fats in the blood. 

Health Secretary Jeremy Hunt has called for a wider roll out of NHS Health Checks in order to save 650 lives a year in England.

The National Institute for Health and Care Excellence has published draft guidance in which it says it is “minded not to recommend” Roche’s MabThera as a treatment for a rare autoimmune disease.

After a leaked memo emerged which suggested that pharma trade associations in Europe and the USA plan to put pressure on patient groups to speak up against publishing raw data, charities have reiterated their support for campaigns to increase transparency.

AstraZeneca has confirmed that it has been visited by Chinese officials but says it involved an individual case and is not part of a wider investigation.

A Small Business Innovation Research (SBIR) grant from the US National Institutes of Health (NIH) has set DNASTAR on the next stage of expanding its sequence assembly and analysis software from general research usage to the clinical-research market.

ReNeuron has raised £33.2 million as part of a package that will see the UK stem cell company relocate from Guilford to Wales.

GlaxoSmithKline has met with Chinese officials to tackle the bribery scandal engulfing the firm and acknowledged that some executives have indeed been involved with illegal activities.

The National Health Service has booked a financial surplus of £2.1 billion for 2012-13, remaining flat with that last year.